Downregulation of neuronal cdk5/p35 in opioid addicts and opiate-treated rats: Relation to neurofilamentphosphorylation

Neuropsychopharmacology

Volumn 28, Issue 5, 2003, Pages 947-955

  Ferrer Alcón, Marcel ^a   La Harpe, Romano ^b   Guimón, José ^a   Garaa Sevilla, Jesus A ^c  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

^c UNIVERSITAT DE LES ILLES BALEARS   (Spain)

Author keywords

Cdk5 p35 kinase complex; Human brain; Neurofilament H phosphorylation; Opioid addiction; Protein p25; Rat brain

Indexed keywords

MORPHINE; NERVE PROTEIN; NEUROFILAMENT PROTEIN; NEUROFILAMENT PROTEIN H; NEURONAL CDK5 ACTIVATOR (P25 P35); NEURONAL CDK5 ACTIVATOR (P25-P35);

ADOLESCENT; ADULT; ANIMAL; ARTICLE; COMPARATIVE STUDY; DOWN REGULATION; DRUG EFFECT; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; NONPARAMETRIC TEST; OPIATE ADDICTION; PHOSPHORYLATION; PHYSIOLOGY; PREFRONTAL CORTEX; RAT; SPRAGUE DAWLEY RAT;

ADOLESCENT; ADULT; ANIMALS; DOWN-REGULATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MORPHINE; NERVE TISSUE PROTEINS; NEUROFILAMENT PROTEINS; OPIOID-RELATED DISORDERS; PHOSPHORYLATION; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; STATISTICS, NONPARAMETRIC;

EID: 0038389083     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/sj.npp.1300095     Document Type: Article

References (35)

1. Bibb JA, Chen J, Taylor JR, Svenningsson P, Nishi A, Snyder GL (2001). Effects of chronic exposure to cocaine are regulated bythe neuronal protein Cdk5.Nature410: 376-380.
2. Dhavan R, Tsai L-H (2001). A decade of CDK5.Nature Rev/Mol Cell Biol2: 749-759.
3. Ferrer-Alcon F, Garcia-Sevilla JA, La Harpe R, Walzer C, Guimon J (1999). Regulation of p35/cyclin-dependent kinase 5 (p35/cdk-5)complex in brains of opioid addicts. S07-10, p 49.
4. Ferrer-Alcon F, Garcia-Sevilla JA, Jaquet PH, La Harpe R, Riederer BM, Walzer C(2000). Regulation of nonphosphorylated andphosphorylated forms of neurofilament proteins in the pre-frontal cortex of human opioid addicts.J Neurosci Res61: 338-349.
5. Fountoulakis M, Hardmeier R, Hoger H, Lubec G (2001). Postmortem changes in the level of brain proteins.Exp Neurol167: 86-94.
6. Garcia-Sevilla JA, Ventayol P, Busquets X, La Harpe R, Walzer C, Guimon J (1997). Marked decrease of immunolabelled 68kDaneurofilament (NF-L) proteins in brains of opiate addicts.Neuro Report8: 1561-1570.
7. Goldberger BA, Cone EJ, Grant T, Caplan YH, Levine BS, Smialek JE (1994). Disposition of heroin and its metabolites in heroin-related deaths.J Anal Toxicol18: 22-28.
8. Grant P, Sharma P, Pant HC (2001). Cyclin-dependent protein kinase 5 (CDK5) and the regulation of neurofilamentmetabo-lism.Eur J Biochem268: 1534-1546.
9. Hellmich MR, Pant HC, Wada E, Battey JF (1992). Neuronal cdc2-like kinase: a CDC2-related protein kinase with predominantly neuronal expression.Proc Natl Acad Sci USA89: 10867-10871.
10. JaquetPh E, Ferrer-Alcon M, Ventayol P, Guimon J, Garcia-Sevilla JA (2001).Acute and chronic effects of morphine and naloxoneon the phosphorylation of neurofilament-H proteins in the ratbrain.Neurosci Lett304: 37-40.
11. Kusakawa G-I, Saito T, Onuki R, Ishiguro K, Kishimoto T, Hisanaga S-I (2000). Calpain-dependent proteolytic cleavage ofthe p35 cyclin-dependent kinase 5 activator to p25.J Biol Chem275: 17166-17172.
12. Law P-Y, Wong YH, Loh HH (2000).Molecular mechanisms and regulation of opioid receptor signaling.Annu Rev Pharmacol40:389-430.
13. Lee M-S, Kwon YT, Li M, Peng J, Friedlander RM, Tsai L-H (2000). Neurotoxicity induces cleavage of p35 to p25 by calpain.Nature405: 360-364.
14. Lew J, Huang Q-Q, Qi Z, Winkfein RJ, Aebersold R, Hunt T (1994). A brain-specific activator of cyclin-dependent kinase 5.Nature371: 423-426.
15. Maccioni RB, Otth C, Concha II, Muüoz JP (2001). The protein kinase Cdk5. Structural aspects, roles in neurogenesis andinvolvement in Alzheimer’s pathology.Eur J Biochem268: 1518-1527.
16. McLeman ER, Warsh JJ, Ang L, Li PP, Kalasinsky KS, Ross BM(2000). The human nucleus accumbens is highly susceptible toG protein down-regulation by methamphetamine and heroin.JNeurochem74: 2120-2126.
17. Meana JJ, Gonzalez-Maeso J, Garcia-Sevilla JA, Guimon J (2000). m -opioid receptor and a2-adrenoceptor agonist stimulation of35SGTPgS binding to G-proteins in postmortem brains of opioidaddicts.Mol Psychiatry5: 308-315.
18. Merril J, Garvey T, Rosson C (1996). Methadone concentrations taken as indicating deaths due to overdose need to be reviewed.Br Med J313: 1481.
19. Nakamura S, Kawamoto Y, Nakano N, Akiguchi I, Kimura J (1997). p35nck5aand cyclin-dependent kinase 5 colocalize in Lewy bodies of brains with Parkinson’s disease.Acta Nueropathol94: 153-157.
20. Nestler EJ (2001).Molecular basis of long-term plasticity under-lying addiction.Nat Rev/Neurosci2: 119-128.
21. Nestler EJ, Barrot M, Self DW (2001).DFosB: a sustained molecular switch for addiction.Proc Natl Acad Sci USA98:11042-11046.
22. Nye HE, Nestler EJ (1996). Induction of chronic Fos-related antigens in rat brain by chronic morphine administration.MolPharmacol49: 636-645.
23. Pant AC, Veeranna GJ, Pant HC, Amin N (1997). Phosphorylation of human high molecular weight neurofilament protein (hNF-H)by neuronal cyclin-dependent kinase 5 (cdk5).Brain Res765:259-266.
24. Patrick GN, Zhou P, Kwon YT, Howley PM, Tsai L-H (1998). p35, the neuronal-specific activator of cyclin-dependent kinase 5(Cdk5) is degraded by the ubiquitin-proteasome pathway.J BiolChem273: 24057-24064.
25. Patrick GN, Zukerberg L, Nikolic M, de la Monte S, Dikkes P, Tsai L-H (1999). Conversion of p35 to p25 deregulates Cdk5activity and promotes neurodegeneration.Nature402: 615-622.
26. Qi Z, Tang D, Zhu X, Fujita DJ, Wang JH (1998). Association of neurofilament proteins with neuronal Cdk5 activator.J BiolChem273: 2329-2335.
27. Sastre M, Garcia-Sevilla JA (1994). Density of alpha-2A adreno-ceptors and Gi proteins in the human brain: ratio of high affinity agonist sites to antagonist sites and effect of age.J PharmacolExp Ther269: 1062-1072.
28. Sun D, Leung CL, Liem RKH (1996). Phosphorylation of the high molecular weight neurofilament protein (NF-H) by Cdk5 andp35.J BiolChem271: 14245-14251.
29. Tagliaro F, De Battisti Z, Smith FP, Marigo M (1998). Death from heroin overdose: findings from hair analysis.Lancet351: 1923-1925.
30. Tang D, Wang JH (1996). Cyclin-dependent kinase 5 (Cdk5) and neuron-specific Cdk5 activators.Prog Cell Cycle Res2: 205-216.
31. Tsai L-H, Delalle I, CavinessJr VS, Chae T, Harlow E (1994). p35 is a neural-specific regulatory subunit of cyclin-dependent kinase5.Nature371: 419-423.
32. Veeranna GJ, Shetty KT, Link WT, Jaffe H, Wang J, Pant HC (1995). Neuronal cyclin-dependent kinase-5 phosphorylationsites in neurofilament protein (NF-H) are dephosphorylated byprotein phosphatase 2A.J Neurochem64: 2681-2690.
33. Veeranna GJ, Shetty KT, Takahashi M, Grant Ph, Pant HC (2000). Cdk5 and MAPK are associated with complexes of cytoskeletalproteins in rat brain.Mol Brain Res76: 229-236.
34. Ventayol P, Busquets X, Garcia-Sevilla JA (1997). Modulation of immunoreactive protein kinase C-a and ß isoforms and Gproteins by acute and chronic treatments with morphine andother opiate drugs in rat brain.Naunyn-Schmiedeberg’s ArchPharmacol355: 491-500.
35. Zheng M, Leung CL, Liem RK (1998). Region-specific expression of cyclin-dependent kinase 5 (Cdk5) and its activators, p35 andp39, in the developing and adult rat central nervous system.JNeurobiol35: 141-159.